• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从英国常规接触者追踪数据看感染 SARS-CoV-2 变异株奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)的症状比较。

Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.

机构信息

Health Protection Operations, Field Services, Contact Tracing Data Management and Surveillance, UK Health Security Agency, London, England.

出版信息

Epidemiol Infect. 2022 Aug 17;150:e162. doi: 10.1017/S0950268822001297.

DOI:10.1017/S0950268822001297
PMID:35975466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9509793/
Abstract

Symptoms are currently used as testing indicators for SARS-CoV-2 in England. In this study, we analysed national contact tracing data for England (NHS Test and Trace) for the period 1 December to 28 December 2021 to explore symptom differences between the variants, Delta and Omicron. We found that at least one of the symptoms currently used as indicators (fever, cough and loss of smell and taste) were reported in 61.5% of Omicron cases and 72.2% in Delta cases, suggesting that these symptoms are less predictive of Omicron infections. Nearly 40% of Omicron infections did not report any of the three key indicative symptoms, reinforcing the importance of the entire spectrum of symptoms for targeted testing. After adjusting for potential confounding factors, fever and cough were more commonly associated with Omicron infections compared to Delta, showing the importance of considering age and vaccination status when assessing symptom profiles. Sore throat was also more commonly reported in Omicron infections, and loss of smell and taste more commonly reported in Delta infections. Our study shows the value of continued monitoring of symptoms associated with SARS-CoV-2, as changes may influence the effectiveness of testing policy and case ascertainment approaches.

摘要

症状目前被用作英国 SARS-CoV-2 的检测指标。在这项研究中,我们分析了 2021 年 12 月 1 日至 12 月 28 日期间英国的全国接触者追踪数据(NHS Test and Trace),以探索德尔塔和奥密克戎变异株之间的症状差异。我们发现,奥密克戎病例中至少有一种目前用作指标的症状(发热、咳嗽和嗅觉味觉丧失)的报告比例为 61.5%,德尔塔病例中为 72.2%,这表明这些症状对奥密克戎感染的预测性较低。近 40%的奥密克戎感染病例未报告这三种主要症状中的任何一种,这进一步强调了针对特定目标进行检测时,整个症状谱的重要性。在调整了潜在混杂因素后,发热和咳嗽与奥密克戎感染的相关性更高,这表明在评估症状谱时,考虑年龄和疫苗接种状态非常重要。奥密克戎感染中更常报告咽痛,而德尔塔感染中更常报告嗅觉味觉丧失。我们的研究表明,继续监测与 SARS-CoV-2 相关的症状具有重要价值,因为这些变化可能会影响检测政策和病例确定方法的有效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ae/9509793/c0f5b1255486/S0950268822001297_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ae/9509793/94df7b49d51b/S0950268822001297_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ae/9509793/c0f5b1255486/S0950268822001297_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ae/9509793/94df7b49d51b/S0950268822001297_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54ae/9509793/c0f5b1255486/S0950268822001297_fig2.jpg

相似文献

1
Comparative symptomatology of infection with SARS-CoV-2 variants Omicron (B.1.1.529) and Delta (B.1.617.2) from routine contact tracing data in England.从英国常规接触者追踪数据看感染 SARS-CoV-2 变异株奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)的症状比较。
Epidemiol Infect. 2022 Aug 17;150:e162. doi: 10.1017/S0950268822001297.
2
COVID-19 Symptoms and Duration of Rapid Antigen Test Positivity at a Community Testing and Surveillance Site During Pre-Delta, Delta, and Omicron BA.1 Periods.在德尔塔和奥密克戎 BA.1 变异株流行期间社区检测和监测点的 COVID-19 症状和快速抗原检测阳性持续时间。
JAMA Netw Open. 2022 Oct 3;5(10):e2235844. doi: 10.1001/jamanetworkopen.2022.35844.
3
Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.2021 年 8 月至 2022 年 3 月,英国青少年在先前感染和接种疫苗后对 delta(B.1.617.2)和 omicron(B.1.1.529)BA.1 和 BA.2 SARS-CoV-2 变异株的症状性感染的保护作用:一项全国性、观察性、基于检测的病例对照研究。
Lancet Infect Dis. 2023 Apr;23(4):435-444. doi: 10.1016/S1473-3099(22)00729-0. Epub 2022 Nov 24.
4
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England.奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的传播比较及疫苗接种的影响:英格兰全国队列研究。
Epidemiol Infect. 2023 Mar 20;151:e58. doi: 10.1017/S0950268823000420.
5
Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.比较分析英国住院和死亡风险与 SARS-CoV-2 奥密克戎(B.1.1.529)和德尔塔(B.1.617.2)变异株的关系:一项队列研究。
Lancet. 2022 Apr 2;399(10332):1303-1312. doi: 10.1016/S0140-6736(22)00462-7. Epub 2022 Mar 16.
6
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.非住院的成年人感染 SARS-CoV-2 亚变体奥密克戎 BA.1、BA.2、BA.4/5 或德尔塔导致的 COVID-19,无论其疫苗接种史如何,其疾病持续时间、症状严重程度和病毒动力学均相似。
PLoS One. 2024 Mar 21;19(3):e0294897. doi: 10.1371/journal.pone.0294897. eCollection 2024.
7
Replacement dynamics and the pathogenesis of the Alpha, Delta and Omicron variants of SARS-CoV-2.SARS-CoV-2 的 Alpha、Delta 和奥密克戎变异株的替代动力学和发病机制。
Epidemiol Infect. 2022 Dec 20;151:e32. doi: 10.1017/S0950268822001935.
8
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.接种加强针后感染 SARS-CoV-2:一项前瞻性、基于社区的病例对照研究中的疾病和症状特征。
J Infect. 2023 Dec;87(6):506-515. doi: 10.1016/j.jinf.2023.08.009. Epub 2023 Sep 28.
9
Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study.日本基于登记的观察性研究:COVID-19 症状与奥密克戎亚变体 BA.2 和 BA.5、宿主状态和临床结局的关联。
Lancet Infect Dis. 2023 Nov;23(11):1244-1256. doi: 10.1016/S1473-3099(23)00271-2. Epub 2023 Jun 30.
10
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.在墨西哥西部,比较感染野生型 SARS-CoV-2、Delta 或 Omicron 变异株的个体的症状、合并症和再感染的流行情况:一项比较研究。
Front Public Health. 2023 Apr 27;11:1149795. doi: 10.3389/fpubh.2023.1149795. eCollection 2023.

引用本文的文献

1
Risk factors for COVID-19 transmission in England: a multilevel modelling study using routine contact tracing data.英国新冠病毒传播的风险因素:一项使用常规接触者追踪数据的多层次建模研究
Epidemiol Infect. 2024 Oct 2;152:e112. doi: 10.1017/S0950268824001043.
2
Comparison of sinonasal symptoms in upper respiratory tract infections during the infectious diseases season of November 2023 to March 2024-a cross-sectional study.2023年11月至2024年3月传染病季节上呼吸道感染时鼻窦症状的比较——一项横断面研究
Front Med (Lausanne). 2024 Aug 29;11:1447467. doi: 10.3389/fmed.2024.1447467. eCollection 2024.
3
Predicting Deterioration from Wearable Sensor Data in People with Mild COVID-19.

本文引用的文献

1
Monitoring the COVID-19 immunisation programme through a national immunisation Management system - England's experience.通过国家免疫管理系统监测 COVID-19 免疫计划——英格兰的经验。
Int J Med Inform. 2023 Feb;170:104974. doi: 10.1016/j.ijmedinf.2022.104974. Epub 2022 Dec 23.
2
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.英国与奥密克戎相关的新冠病毒症状变化
Clin Infect Dis. 2022 Aug 3;76(3):e133-41. doi: 10.1093/cid/ciac613.
3
SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo.
从轻度 COVID-19 患者的可穿戴传感器数据预测病情恶化。
Sensors (Basel). 2023 Dec 4;23(23):9597. doi: 10.3390/s23239597.
4
Changes in symptoms and characteristics of COVID-19 patients across different variants: two years study using neural network analysis.不同变异株 COVID-19 患者症状和特征的变化:使用神经网络分析的两年研究。
BMC Infect Dis. 2023 Nov 28;23(1):838. doi: 10.1186/s12879-023-08813-9.
5
COVID-19-Associated Chemosensory Loss Continues to Decline.新冠病毒相关嗅觉丧失持续下降。
Otolaryngol Head Neck Surg. 2023 Nov;169(5):1386-1389. doi: 10.1002/ohn.384. Epub 2023 May 26.
6
Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies.SARS-CoV-2 变异株的进化:对免疫逃逸、疫苗接种、治疗和诊断策略的影响。
Viruses. 2023 Apr 10;15(4):944. doi: 10.3390/v15040944.
7
Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-Analysis.奥密克戎变异株导致嗅觉功能障碍的流行情况:一项系统评价和荟萃分析。
Cells. 2023 Jan 28;12(3):430. doi: 10.3390/cells12030430.
8
Prevalence of Olfactory Dysfunction with the Omicron Variant of SARS-CoV-2: A Systematic Review and Meta-analysis.新型冠状病毒奥密克戎变异株导致嗅觉功能障碍的患病率:一项系统评价和荟萃分析
medRxiv. 2023 Jan 19:2022.12.16.22283582. doi: 10.1101/2022.12.16.22283582.
9
Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.新冠疫情期间嗅觉丧失和味觉障碍的发病机制和进展。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):505-509. doi: 10.1007/s00405-022-07689-w. Epub 2022 Oct 9.
严重急性呼吸综合征冠状病毒2型奥密克戎变异株在人支气管和肺组织外植体中的复制
Nature. 2022 Mar;603(7902):715-720. doi: 10.1038/s41586-022-04479-6. Epub 2022 Feb 1.
4
The omicron (B.1.1.529) SARS-CoV-2 variant of concern does not readily infect Syrian hamsters.奥密克戎(B.1.1.529)关切变异株不易感染叙利亚仓鼠。
Antiviral Res. 2022 Feb;198:105253. doi: 10.1016/j.antiviral.2022.105253. Epub 2022 Jan 21.
5
COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study.入院时的 COVID-19 症状因年龄和性别而异:来自 ISARIC 前瞻性多国观察性研究的结果。
Infection. 2021 Oct;49(5):889-905. doi: 10.1007/s15010-021-01599-5. Epub 2021 Jun 25.
6
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
7
Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness.嗅觉和味觉变化是 COVID-19 大流行和政治决策有效性的早期指标。
Nat Commun. 2020 Oct 14;11(1):5152. doi: 10.1038/s41467-020-18963-y.
8
Modeling the Onset of Symptoms of COVID-19.建模 COVID-19 症状的发作。
Front Public Health. 2020 Aug 13;8:473. doi: 10.3389/fpubh.2020.00473. eCollection 2020.
9
Real-time tracking of self-reported symptoms to predict potential COVID-19.实时跟踪自我报告的症状以预测潜在的 COVID-19。
Nat Med. 2020 Jul;26(7):1037-1040. doi: 10.1038/s41591-020-0916-2. Epub 2020 May 11.